Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung?

[1]  W. Bamlet,et al.  Study design considerations in clinical outcome research of lung cancer using microarray analysis. , 2004, Lung cancer.

[2]  Ping Yang,et al.  Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. , 2004, The Annals of thoracic surgery.

[3]  Iver Petersen,et al.  Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis , 2003, The Journal of pathology.

[4]  Sorin Drăghici,et al.  Data Analysis Tools for DNA Microarrays , 2003 .

[5]  H. Kato,et al.  cDNA microarray analysis of gene expression in pathologic stage IA nonsmall cell lung carcinomas , 2003, Cancer.

[6]  Yusuke Nakamura,et al.  Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs , 2003, Oncogene.

[7]  Avrum Spira,et al.  Gene expression in lung adenocarcinomas of smokers and nonsmokers. , 2003, American journal of respiratory cell and molecular biology.

[8]  David E. Misek,et al.  RANTES expression is a predictor of survival in stage I lung adenocarcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  M. Brundage,et al.  Prognostic factors in non-small cell lung cancer: a decade of progress. , 2002, Chest.

[10]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[11]  S. Knuutila,et al.  Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array , 2002, Oncogene.

[12]  M. Tyers,et al.  Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. , 2002, Cancer research.

[13]  L. Liotta,et al.  Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. , 2002, Cancer research.

[14]  M. Zajac-Kaye,et al.  Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. , 2001, Lung cancer.

[15]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Lafitte,et al.  Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. , 2001, The European respiratory journal.

[17]  Cheng Li,et al.  Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application , 2001, Genome Biology.

[18]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Mitsudomi,et al.  Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D M Parkin,et al.  Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. , 1997, European journal of cancer.

[22]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[23]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..

[24]  J. Hornaday,et al.  Cancer Facts & Figures 2004 , 2004 .

[25]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[26]  D. Stekel.  Microarray Bioinformatics: Analysis of Relationships Between Genes, Tissues or Treatments , 2003 .

[27]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Volm,et al.  Prognostic relevance of c-Myc and caspase-3 for patients with non-small cell lung cancer. , 2000, Oncology reports.

[29]  R. Fletcher,et al.  Clinical Epidemiology: The Essentials , 1982 .